Atlas Trials

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Clinical trial NCT05313165 · RECRUITING

Trial details

NCT number
NCT05313165
Sponsor
LimFlow, Inc.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Critical Limb IschemiaChronic Limb-Threatening IschemiaPeripheral Arterial Disease
Start date
2022-12-22
Primary completion
2027-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.